AtriCure, Inc. (ATRC) vs Pulse Biosciences, Inc (PLSE)
- AtriCure, Inc. ATRC 56.09 −2.92%
- Pulse Biosciences, Inc PLSE 44.27 −2.90%
AtriCure, Inc. and Pulse Biosciences, Inc are both Medical Instruments & Supplies companies. Pulse Biosciences, Inc is the larger, with a market value of $3.3B against $2.9B — 1.1× the size. Pulse Biosciences, Inc has negative trailing earnings, so its P/E is not meaningful; AtriCure, Inc. trades at 259×. AtriCure, Inc. grew revenue faster over the last twelve months: 13.9% against −23.3%. AtriCure, Inc. has the higher net margin (1.85% vs −6,755.8%) and the higher return on invested capital (1.92% vs 0.00%). Across the 17 metrics below, AtriCure, Inc. leads on 15 and Pulse Biosciences, Inc on 2.
Valuation
Profitability
| Metric | ATRC | PLSE | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 76.30% | 0.25% | 54.29% |
| Operating margin | 2.26% | (7,007.76%) | 1.07% |
| Net margin | 1.85% | (6,755.78%) | (1.61%) |
| Free cash flow margin | 9.32% | (5,180.42%) | 1.08% |
| Return on equity | 2.15% | (78.49%) | (1.32%) |
| Return on assets | 1.64% | (67.90%) | 0.00% |
| Return on invested capital | 1.92% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack